List of Tables
Table 1. Molecular Diagnosis of Tumors Market Trends
Table 2. Molecular Diagnosis of Tumors Market Drivers & Opportunity
Table 3. Molecular Diagnosis of Tumors Market Challenges
Table 4. Molecular Diagnosis of Tumors Market Restraints
Table 5. Global Molecular Diagnosis of Tumors Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Molecular Diagnosis of Tumors Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Molecular Diagnosis of Tumors Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Molecular Diagnosis of Tumors Product Type
Table 9. Key Companies Time to Begin Mass Production of Molecular Diagnosis of Tumors
Table 10. Global Molecular Diagnosis of Tumors Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnosis of Tumors as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Molecular Diagnosis of Tumors Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Molecular Diagnosis of Tumors Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Molecular Diagnosis of Tumors Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Molecular Diagnosis of Tumors Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Molecular Diagnosis of Tumors Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Molecular Diagnosis of Tumors Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Molecular Diagnosis of Tumors Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Molecular Diagnosis of Tumors Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Molecular Diagnosis of Tumors Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Molecular Diagnosis of Tumors Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Molecular Diagnosis of Tumors Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Molecular Diagnosis of Tumors Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Molecular Diagnosis of Tumors Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Molecular Diagnosis of Tumors Sales Value by Region (2019-2024) & (%)
Table 27. Global Molecular Diagnosis of Tumors Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Molecular Diagnosis of Tumors Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Molecular Diagnosis of Tumors Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Molecular Diagnosis of Tumors Sales Value, (2025-2030) & (US$ Million)
Table 31. Abbott Laboratories Basic Information List
Table 32. Abbott Laboratories Description and Business Overview
Table 33. Abbott Laboratories Molecular Diagnosis of Tumors Products, Services and Solutions
Table 34. Revenue (US$ Million) in Molecular Diagnosis of Tumors Business of Abbott Laboratories (2019-2024)
Table 35. Abbott Laboratories Recent Developments
Table 36. Roche Holding Basic Information List
Table 37. Roche Holding Description and Business Overview
Table 38. Roche Holding Molecular Diagnosis of Tumors Products, Services and Solutions
Table 39. Revenue (US$ Million) in Molecular Diagnosis of Tumors Business of Roche Holding (2019-2024)
Table 40. Roche Holding Recent Developments
Table 41. Thermo Fisher Scientific Basic Information List
Table 42. Thermo Fisher Scientific Description and Business Overview
Table 43. Thermo Fisher Scientific Molecular Diagnosis of Tumors Products, Services and Solutions
Table 44. Revenue (US$ Million) in Molecular Diagnosis of Tumors Business of Thermo Fisher Scientific (2019-2024)
Table 45. Thermo Fisher Scientific Recent Developments
Table 46. Danaher Corporation Basic Information List
Table 47. Danaher Corporation Description and Business Overview
Table 48. Danaher Corporation Molecular Diagnosis of Tumors Products, Services and Solutions
Table 49. Revenue (US$ Million) in Molecular Diagnosis of Tumors Business of Danaher Corporation (2019-2024)
Table 50. Danaher Corporation Recent Developments
Table 51. Veracyte Basic Information List
Table 52. Veracyte Description and Business Overview
Table 53. Veracyte Molecular Diagnosis of Tumors Products, Services and Solutions
Table 54. Revenue (US$ Million) in Molecular Diagnosis of Tumors Business of Veracyte (2019-2024)
Table 55. Veracyte Recent Developments
Table 56. TBG Diagnostics Basic Information List
Table 57. TBG Diagnostics Description and Business Overview
Table 58. TBG Diagnostics Molecular Diagnosis of Tumors Products, Services and Solutions
Table 59. Revenue (US$ Million) in Molecular Diagnosis of Tumors Business of TBG Diagnostics (2019-2024)
Table 60. TBG Diagnostics Recent Developments
Table 61. Agilient Technologies Basic Information List
Table 62. Agilient Technologies Description and Business Overview
Table 63. Agilient Technologies Molecular Diagnosis of Tumors Products, Services and Solutions
Table 64. Revenue (US$ Million) in Molecular Diagnosis of Tumors Business of Agilient Technologies (2019-2024)
Table 65. Agilient Technologies Recent Developments
Table 66. Illumina Basic Information List
Table 67. Illumina Description and Business Overview
Table 68. Illumina Molecular Diagnosis of Tumors Products, Services and Solutions
Table 69. Revenue (US$ Million) in Molecular Diagnosis of Tumors Business of Illumina (2019-2024)
Table 70. Illumina Recent Developments
Table 71. Genecast Basic Information List
Table 72. Genecast Description and Business Overview
Table 73. Genecast Molecular Diagnosis of Tumors Products, Services and Solutions
Table 74. Revenue (US$ Million) in Molecular Diagnosis of Tumors Business of Genecast (2019-2024)
Table 75. Genecast Recent Developments
Table 76. Burning Rock Biotech Basic Information List
Table 77. Burning Rock Biotech Description and Business Overview
Table 78. Burning Rock Biotech Molecular Diagnosis of Tumors Products, Services and Solutions
Table 79. Revenue (US$ Million) in Molecular Diagnosis of Tumors Business of Burning Rock Biotech (2019-2024)
Table 80. Burning Rock Biotech Recent Developments
Table 81. Key Raw Materials Lists
Table 82. Raw Materials Key Suppliers Lists
Table 83. Molecular Diagnosis of Tumors Downstream Customers
Table 84. Molecular Diagnosis of Tumors Distributors List
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Molecular Diagnosis of Tumors Product Picture
Figure 2. Global Molecular Diagnosis of Tumors Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Molecular Diagnosis of Tumors Sales Value (2019-2030) & (US$ Million)
Figure 4. Molecular Diagnosis of Tumors Report Years Considered
Figure 5. Global Molecular Diagnosis of Tumors Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Molecular Diagnosis of Tumors Revenue in 2023
Figure 7. Molecular Diagnosis of Tumors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. NGS-Based Picture
Figure 9. PCR-Based Picture
Figure 10. Global Molecular Diagnosis of Tumors Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Molecular Diagnosis of Tumors Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Hospitals
Figure 13. Product Picture of Diagnostic Centers
Figure 14. Product Picture of Others
Figure 15. Global Molecular Diagnosis of Tumors Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Molecular Diagnosis of Tumors Sales Value Market Share by Application, 2023 & 2030
Figure 17. North America Molecular Diagnosis of Tumors Sales Value (2019-2030) & (US$ Million)
Figure 18. North America Molecular Diagnosis of Tumors Sales Value by Country (%), 2023 VS 2030
Figure 19. Europe Molecular Diagnosis of Tumors Sales Value (2019-2030) & (US$ Million)
Figure 20. Europe Molecular Diagnosis of Tumors Sales Value by Country (%), 2023 VS 2030
Figure 21. Asia Pacific Molecular Diagnosis of Tumors Sales Value (2019-2030) & (US$ Million)
Figure 22. Asia Pacific Molecular Diagnosis of Tumors Sales Value by Country (%), 2023 VS 2030
Figure 23. South America Molecular Diagnosis of Tumors Sales Value (2019-2030) & (US$ Million)
Figure 24. South America Molecular Diagnosis of Tumors Sales Value by Country (%), 2023 VS 2030
Figure 25. Middle East & Africa Molecular Diagnosis of Tumors Sales Value (2019-2030) & (US$ Million)
Figure 26. Middle East & Africa Molecular Diagnosis of Tumors Sales Value by Country (%), 2023 VS 2030
Figure 27. Key Countries/Regions Molecular Diagnosis of Tumors Sales Value (%), (2019-2030)
Figure 28. United States Molecular Diagnosis of Tumors Sales Value, (2019-2030) & (US$ Million)
Figure 29. United States Molecular Diagnosis of Tumors Sales Value by Type (%), 2023 VS 2030
Figure 30. United States Molecular Diagnosis of Tumors Sales Value by Application (%), 2023 VS 2030
Figure 31. Europe Molecular Diagnosis of Tumors Sales Value, (2019-2030) & (US$ Million)
Figure 32. Europe Molecular Diagnosis of Tumors Sales Value by Type (%), 2023 VS 2030
Figure 33. Europe Molecular Diagnosis of Tumors Sales Value by Application (%), 2023 VS 2030
Figure 34. China Molecular Diagnosis of Tumors Sales Value, (2019-2030) & (US$ Million)
Figure 35. China Molecular Diagnosis of Tumors Sales Value by Type (%), 2023 VS 2030
Figure 36. China Molecular Diagnosis of Tumors Sales Value by Application (%), 2023 VS 2030
Figure 37. Japan Molecular Diagnosis of Tumors Sales Value, (2019-2030) & (US$ Million)
Figure 38. Japan Molecular Diagnosis of Tumors Sales Value by Type (%), 2023 VS 2030
Figure 39. Japan Molecular Diagnosis of Tumors Sales Value by Application (%), 2023 VS 2030
Figure 40. South Korea Molecular Diagnosis of Tumors Sales Value, (2019-2030) & (US$ Million)
Figure 41. South Korea Molecular Diagnosis of Tumors Sales Value by Type (%), 2023 VS 2030
Figure 42. South Korea Molecular Diagnosis of Tumors Sales Value by Application (%), 2023 VS 2030
Figure 43. Southeast Asia Molecular Diagnosis of Tumors Sales Value, (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Molecular Diagnosis of Tumors Sales Value by Type (%), 2023 VS 2030
Figure 45. Southeast Asia Molecular Diagnosis of Tumors Sales Value by Application (%), 2023 VS 2030
Figure 46. India Molecular Diagnosis of Tumors Sales Value, (2019-2030) & (US$ Million)
Figure 47. India Molecular Diagnosis of Tumors Sales Value by Type (%), 2023 VS 2030
Figure 48. India Molecular Diagnosis of Tumors Sales Value by Application (%), 2023 VS 2030
Figure 49. Molecular Diagnosis of Tumors Industrial Chain
Figure 50. Molecular Diagnosis of Tumors Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
